ATRECA INC TECH CODE: Istoricul versiunilor

24 noiembrie 2024

• actualăprec 10:5924 noiembrie 2024 10:59‎ 127.0.0.1 discuție‎ 1.401 octeți +4‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 15:4118 septembrie 2024 15:41‎ Admin discuție contribuții‎ 1.397 de octeți +1.397‎ Pagină nouă: Pagina dedicata companiei ATRECA INC TECH CODE listata cu simbolul US.BCEL ==Descriere companie== Atreca, Inc. (www.atreca.com) is a clinical-stage biopharmaceutical company. The Company use its platform to discover and develop antibody-based immunotherapeutic to treat a range of solid tumor types. The Company's lead product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. It...